Treatment of Refractory Hematospermia With Finasteride: A Prospective Placebo-Controlled Study

    October 2023 in “ Bangladesh journal of urology
    Imtiaz Enayetullah, Md Asaduzzaman Rajib, Sharif Md Shahadat Ali Khan, Mahjabin Joarder, Tanbir Al Misbah, Md Faisal Islam
    Image of study
    TLDR Finasteride effectively treats hematospermia in 3 months without side effects.
    This prospective placebo-controlled study evaluated the efficacy of finasteride in treating refractory idiopathic hematospermia in 22 patients. The study found that 81% of patients treated with finasteride experienced cessation of hematospermia after 3 months, compared to 27% in the placebo group (P = 0.03). Remission occurred in 45% of finasteride-treated patients within 1 month, and although hematospermia recurred in some patients after stopping treatment, a significant decrease in bleeding frequency and amount was observed. The study concludes that a 3-month finasteride treatment significantly cures hematospermia without undesirable side effects.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results